Related Experiment Video
Updated: Sep 4, 2025

Author Spotlight: Noninvasive Cerebral Blood Flow Determination in Human Functional Brain Region for Diagnosis of Neurological Disorders
Published on: May 31, 2024
A Bayesian estimation method for cerebral blood flow measurement by area-detector CT perfusion imaging
Kazuhiro Murayama1, Ewoud J Smit2, Mathias Prokop2
1Department of Radiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-Cho Toyoake, Aichi, 470-1101, Japan. kmura@fujita-hu.ac.jp.
Bayesian estimation with advanced noise reduction (BEANR) in CT perfusion (CTP) offers more reliable cerebral blood flow (CBF) measurements than reformulated singular value decomposition (rSVD). BEANR demonstrates superior utility compared to rSVD for CTP in cerebrovascular disease patients.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Cerebral blood flow (CBF) is a critical parameter in assessing cerebrovascular disease.
- CT perfusion (CTP) is a widely used imaging technique for CBF measurement.
- Traditional CTP analysis methods, such as reformulated singular value decomposition (rSVD), may have limitations in accuracy.
Purpose of the Study:
- To compare the efficacy of Bayesian estimation with advanced noise reduction (BEANR) versus rSVD for CBF measurement using CTP.
- To evaluate both CTP methods against N-isopropyl-p-[(123)I]-iodoamphetamine (123I-IMP) single-photon emission computed tomography (SPECT) as a reference standard.
- To assess the performance of BEANR and rSVD in patients with cerebrovascular disease.
Main Methods:
- Thirty-one patients with suspected cerebrovascular disease underwent CTP and SPECT.
- CBF maps were generated using both BEANR and rSVD algorithms.
- CBF indices (ischemic to contralateral) were calculated and compared to SPECT using correlation and Bland-Altman analyses.
Main Results:
- BEANR showed a significant positive correlation with 123I-IMP SPECT (r=0.55, p<0.0001).
- No significant correlation was found between rSVD and SPECT (r=0.15, p>0.05).
- BEANR demonstrated smaller limits of agreement and a significantly different mean difference in CBF index compared to rSVD when evaluated against SPECT.
Conclusions:
- BEANR offers superior potential utility for CBF measurement in CTP compared to rSVD.
- BEANR provides more reliable CBF quantification in patients with cerebrovascular disease.
- The findings suggest BEANR is a promising advancement for CTP analysis in clinical practice.

